Among 1,399 breast cancers newly diagnosed in Mauritius from 2017 to 2020, net survival was 93.9% at one year and 83.4% at three years. About two thirds were diagnosed at stage 1 or 2.
Published as "Breast cancer survival analysis in the Republic of Mauritius by age, stage at diagnosis and molecular subtype: A retrospective cohort study" (online September 2024, in print 2025). The authors identified 1,399 breast cancers newly diagnosed between 2017 and 2020 at the Central Health Laboratory, Victoria Hospital, grouped them into five molecular subtypes, and estimated net survival at one and three years by age group, stage and subtype.
Mauritius can measure breast cancer survival from its own records. The authors call for a national breast screening programme, earlier stage at diagnosis and subtype testing for every breast cancer.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/